Antioxidant therapy in hemodialysis patients

Rafieian-Kopaei, M. and Beyki, A. and Nasri, H. (2014) Antioxidant therapy in hemodialysis patients. Journal of Isfahan Medical School, 31 (261).


Download (143kB) | Preview
Official URL:


Cardiovascular problem is the major cause of mortality and morbidity in patients under hemodialysis for chronic kidney disease. Increased lipid peroxidation and depletion of chain-breaking antioxidants may be related to increased risk of atherosclerosis. Oxidative stress and acute phase inflammation are now defined to be highly prevalent in the hemodialysis patients, and several lines of evidence point to their contribution in atherosclerosis development. Antioxidants have been used as therapies to decrease oxidative stress and improve risk of cardiovascular diseases (CVD) in hemodialysis patients. However, plants and fruits antioxidants are reliable ones. Probably, because plants antioxidants are a mixture of several substances with antioxidant activity, which each one supports the other one.

Item Type: Article
Additional Information: cited By 4
Uncontrolled Keywords: antioxidant, antioxidant activity; antioxidant depletion; atherosclerosis; cardiovascular disease; cardiovascular risk; depletion; hemodialysis patient; human; letter; lipid peroxidation; oxidative stress
Subjects: WJ Urogenital System
QV pharmacology
Divisions: Reserach Vice-Chancellar Department > Medical Plants Research Center
Depositing User: Users 1 not found.
Date Deposited: 02 Aug 2017 05:38
Last Modified: 02 Aug 2017 05:38

Actions (login required)

View Item View Item